Today news
About the same in other media
'Sympathy goes out to...': AstraZeneca reaffirms safety of Covishield, Vaxzevria vaccines amid blood clot concerns
Reading now: 805
AstraZeneca had partnered with the Serum Institute of India (SII), the world's largest vaccine manufacturer, to supply the vaccine to the Indian Government. The Serum Institute of India produced a COVID-19 vaccine named Covishield.
Thrombosis Thrombocytopenia Syndrome (TTS) is a rare but serious condition characterized by blood clot formation (thrombosis) and low levels of platelets in the blood (thrombocytopenia). It can be a rare side effect following vaccination, particularly with adenovirus vector-based COVID-19 vaccines.
Read more on livemint.comAbout this in other media
Car driver runs over toll plaza staff on Delhi-Meerut expressway; CCTV video goes viral | Watch livemint.com /6 months ago
‘Temple that i built…': Rohit Sharma chat with Abhishek Nayar goes viral ahead of KKR vs MI clash today livemint.com /6 months ago
Novavax soars 146% on $1.2 billion Sanofi vaccine licensing deal economictimes.indiatimes.com /6 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
